The Annual International Conference of the Egyptian Association for Cancer Research (EACR): Anti-Cancer Drug Discovery

Abstract

The future depends on the welfare of human beings by providing better health through research and technology. Biomedical research is of extreme importance to exploring and finding the human needs in particular new therapies for illnesses such as cancer. Indeed, cancer represents a global medical and economical challenge since it is a burden on the patients, families, physicians, and the government. Given the resistance of cancer cells to chemotherapy, it is of paramount importance for scientists to work on the discovery and development of new drugs that can reach the clinical market. As such, the Egyptian Association for Cancer Research (EACR) successfully organized its annual international conference under the title of “Anti-Cancer Drug Discovery (ACDD-2019) which was held from 21-22 April, 2019 at Tanta University convention Center, Tanta University, Tanta City, Egypt. ACDD-2019 (http://acdd.tanta.edu.eg/) represented an outstanding opportunity for sharing thoughts and idea for research from USA, China, Japan, KSA and other countries with the main goal to come up with the most effective translational anti-cancer agents. The conference included 3 main sessions on day 1 and 8 sessions on day 2. Day 1 included 13 keynote speakers covering different subjects in anti-cancer drug discovery and development including approached based on nanoparticles, gene therapy, immunotherapy and natural and synthetic compounds. Day 2 focused mainly on 5 topics including: 1) the roles of center of excellence of scientific research in drug discovery, 2) parasite and marine compounds and cancer, 3) natural and synthetic anti-cancer drugs, 4) molecular oncology and cancer stem cells, and 5) cancer immunology and immunotherapy. As the president of EACR and Chairman of ACDD-2019, thank you to all who have contributed to this great work.